MTPH.L
Midatech Pharma PLC
Price:  
3.75 
GBP
Volume:  
131,478.00
United Kingdom | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MTPH.L WACC - Weighted Average Cost of Capital

The WACC of Midatech Pharma PLC (MTPH.L) is 6.8%.

The Cost of Equity of Midatech Pharma PLC (MTPH.L) is 8.10%.
The Cost of Debt of Midatech Pharma PLC (MTPH.L) is 5.50%.

Range Selected
Cost of equity 6.90% - 9.30% 8.10%
Tax rate 9.60% - 11.70% 10.65%
Cost of debt 4.00% - 7.00% 5.50%
WACC 5.5% - 8.0% 6.8%
WACC

MTPH.L WACC calculation

Category Low High
Long-term bond rate 4.4% 4.9%
Equity market risk premium 6.4% 7.4%
Adjusted beta 0.39 0.52
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.90% 9.30%
Tax rate 9.60% 11.70%
Debt/Equity ratio 0.72 0.72
Cost of debt 4.00% 7.00%
After-tax WACC 5.5% 8.0%
Selected WACC 6.8%